RWC Update: Impact of Aflibercept 2 mg Biosimilars on Retinal Disease Management; Power of the Needle; Proliferative Vitreoretinopathy

Ophthalmic surgery, lasers & imaging retina 2026 Open access

Read full text
Authors: Ashish Sharma, Lihteh Wu, Steven Bloom, Paulo Eduardo Stanga, Ashish Sharma, Se Joon Woo, Kanwaljeet Harjot Madan, Shishir Verghese, Kourous A. Rezaei
DOI: 10.3928/23258160-20251222-01
Cited by: 0
References: 8

Fields of Study & Subjects

Retinal Diseases and Treatments Drug-Induced Ocular Toxicity Retinal and Optic Conditions

Publication details

Journal / source
Ophthalmic surgery, lasers & imaging retina
Publisher
SLACK, Inc.
Volume
57
Issue
1
Pages
5–8
Publication date
1 January 2026
Language
EN